314 related articles for article (PubMed ID: 24821431)
21. Apolipoprotein B-100 kinetics and static plasma indices of triglyceride-rich lipoprotein metabolism in overweight men.
Chan DC; Watts GF; Ng TW; Uchida Y; Sakai N; Yamashita S; Barrett PH
Clin Biochem; 2005 Sep; 38(9):806-12. PubMed ID: 15992790
[TBL] [Abstract][Full Text] [Related]
22. The hyperenergetic-fed obese dog, a model of disturbance of apolipoprotein B-100 metabolism associated with insulin resistance: kinetic study using stable isotopes.
Briand F; Bailhache E; Andre A; Magot T; Krempf M; Nguyen P; Ouguerram K
Metabolism; 2008 Jul; 57(7):966-72. PubMed ID: 18555839
[TBL] [Abstract][Full Text] [Related]
23. Variation in Niemann-Pick C1-like 1 gene as a determinant of apolipoprotein B-100 kinetics and response to statin therapy in centrally obese men.
Chan DC; Watts GF; Wang J; Hegele RA; van Bockxmeer FM; Barrett PH
Clin Endocrinol (Oxf); 2008 Jul; 69(1):45-51. PubMed ID: 18031309
[TBL] [Abstract][Full Text] [Related]
24. Rate of production of plasma and very-low-density lipoprotein (VLDL) apolipoprotein C-III is strongly related to the concentration and level of production of VLDL triglyceride in male subjects with different body weights and levels of insulin sensitivity.
Cohn JS; Patterson BW; Uffelman KD; Davignon J; Steiner G
J Clin Endocrinol Metab; 2004 Aug; 89(8):3949-55. PubMed ID: 15292332
[TBL] [Abstract][Full Text] [Related]
25. Regulatory effects of HMG CoA reductase inhibitor and fish oils on apolipoprotein B-100 kinetics in insulin-resistant obese male subjects with dyslipidemia.
Chan DC; Watts GF; Barrett PH; Beilin LJ; Redgrave TG; Mori TA
Diabetes; 2002 Aug; 51(8):2377-86. PubMed ID: 12145148
[TBL] [Abstract][Full Text] [Related]
26. Estimated liver weight is directly related to hepatic very low-density lipoprotein-triglyceride secretion rate in men.
Tsekouras YE; Magkos F; Kavouras SA; Panagiotakos DB; Sidossis LS
Eur J Clin Invest; 2008 Sep; 38(9):656-62. PubMed ID: 18837742
[TBL] [Abstract][Full Text] [Related]
27. The effect of a six-month exercise program on very low-density lipoprotein apolipoprotein B secretion in type 2 diabetes.
Alam S; Stolinski M; Pentecost C; Boroujerdi MA; Jones RH; Sonksen PH; Umpleby AM
J Clin Endocrinol Metab; 2004 Feb; 89(2):688-94. PubMed ID: 14764782
[TBL] [Abstract][Full Text] [Related]
28. Plasma apolipoprotein C-III transport in centrally obese men: associations with very low-density lipoprotein apolipoprotein B and high-density lipoprotein apolipoprotein A-I metabolism.
Chan DC; Nguyen MN; Watts GF; Barrett PH
J Clin Endocrinol Metab; 2008 Feb; 93(2):557-64. PubMed ID: 18000086
[TBL] [Abstract][Full Text] [Related]
29. Antiretroviral treatment reduces very-low-density lipoprotein and intermediate-density lipoprotein apolipoprotein B fractional catabolic rate in human immunodeficiency virus-infected patients with mild dyslipidemia.
Shahmanesh M; Das S; Stolinski M; Shojaee-Moradie F; Jackson NC; Jefferson W; Cramb R; Nightingale P; Umpleby AM
J Clin Endocrinol Metab; 2005 Feb; 90(2):755-60. PubMed ID: 15522931
[TBL] [Abstract][Full Text] [Related]
30. Association of Plasma Ceramides and Sphingomyelin With VLDL apoB-100 Fractional Catabolic Rate Before and After Rosuvastatin Treatment.
Ng TW; Ooi EM; Watts GF; Chan DC; Meikle PJ; Barrett PH
J Clin Endocrinol Metab; 2015 Jun; 100(6):2497-501. PubMed ID: 25816050
[TBL] [Abstract][Full Text] [Related]
31. Nicotinic acid decreases apolipoprotein B100-containing lipoprotein levels by reducing hepatic very low density lipoprotein secretion through a possible diacylglycerol acyltransferase 2 inhibition in obese dogs.
Le Bloc'h J; Leray V; Chetiveaux M; Freuchet B; Magot T; Krempf M; Nguyen P; Ouguerram K
J Pharmacol Exp Ther; 2010 Aug; 334(2):583-9. PubMed ID: 20442223
[TBL] [Abstract][Full Text] [Related]
32. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
[TBL] [Abstract][Full Text] [Related]
33. Genotypic associations of the hepatic secretion of VLDL apolipoprotein B-100 in obesity.
Watts GF; Riches FM; Humphries SE; Talmud PJ; van Bockxmeer FM
J Lipid Res; 2000 Mar; 41(3):481-8. PubMed ID: 10706596
[TBL] [Abstract][Full Text] [Related]
34. Effects of bariatric surgery on hepatic and intestinal lipoprotein particle metabolism in obese, nondiabetic humans.
Padilla N; Maraninchi M; Béliard S; Berthet B; Nogueira JP; Wolff E; Nicolay A; Bégu A; Dubois N; Grangeot R; Mattei C; Vialettes B; Xiao C; Lewis GF; Valéro R
Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2330-7. PubMed ID: 25104797
[TBL] [Abstract][Full Text] [Related]
35. A Palaeolithic-type diet causes strong tissue-specific effects on ectopic fat deposition in obese postmenopausal women.
Ryberg M; Sandberg S; Mellberg C; Stegle O; Lindahl B; Larsson C; Hauksson J; Olsson T
J Intern Med; 2013 Jul; 274(1):67-76. PubMed ID: 23414424
[TBL] [Abstract][Full Text] [Related]
36. Kinetics of very-low-density lipoprotein apolipoprotein B-100 in normolipidemic subjects: pooled analysis of stable-isotope studies.
Watts GF; Moroz P; Barrett PH
Metabolism; 2000 Sep; 49(9):1204-10. PubMed ID: 11016905
[TBL] [Abstract][Full Text] [Related]
37. Kinetic and Related Determinants of Plasma Triglyceride Concentration in Abdominal Obesity: Multicenter Tracer Kinetic Study.
Borén J; Watts GF; Adiels M; Söderlund S; Chan DC; Hakkarainen A; Lundbom N; Matikainen N; Kahri J; Vergès B; Barrett PH; Taskinen MR
Arterioscler Thromb Vasc Biol; 2015 Oct; 35(10):2218-24. PubMed ID: 26315407
[TBL] [Abstract][Full Text] [Related]
38. Circulating very-low-density lipoprotein characteristics resulting from fatty liver in an insulin resistance rat model.
Zago V; Lucero D; Macri EV; Cacciagiú L; Gamba CA; Miksztowicz V; Berg G; Wikinski R; Friedman S; Schreier L
Ann Nutr Metab; 2010; 56(3):198-206. PubMed ID: 20203480
[TBL] [Abstract][Full Text] [Related]
39. Adipocytokines and VLDL metabolism: independent regulatory effects of adiponectin, insulin resistance, and fat compartments on VLDL apolipoprotein B-100 kinetics?
Ng TW; Watts GF; Farvid MS; Chan DC; Barrett PH
Diabetes; 2005 Mar; 54(3):795-802. PubMed ID: 15734858
[TBL] [Abstract][Full Text] [Related]
40. Apolipoprotein B signal peptide and apolipoprotein E genotypes as determinants of the hepatic secretion of VLDL apoB in obese men.
Riches FM; Watts GF; van Bockxmeer FM; Hua J; Song S; Humphries SE; Talmud PJ
J Lipid Res; 1998 Sep; 39(9):1752-8. PubMed ID: 9741687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
